Category Specific RSS

Immuron

Immuron enrols first patients into Phase 2 trials for treatment to combat infectious diarrhea

Infectious diarrhea could soon be not so infectious with confirmation from biotech company Immuron (ASX: IMC) that the first patients…

2 years ago